XML 67 R20.htm IDEA: XBRL DOCUMENT v3.25.1
Intangible Assets
12 Months Ended
Dec. 31, 2024
Intangible assets other than goodwill [abstract]  
Intangible Assets Intangible Assets
Rights to
Produce and
Distribute Coca-Cola Trademark Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2022Ps.75,396 Ps.57,351 Ps.8,073 Ps.1,413 Ps.142,233 Ps.10,661 Ps.10,800 Ps.2,006 Ps.2,470 Ps.25,937 Ps.168,170 
Additions — 22 — 12 34 672 — 50 1,476 2,198 2,232 
Acquisitions from business combinations (see Note 4) 1,116 33,715 1,077 — 35,908 373 — — 1,054 1,427 37,335 
Changes in fair value of past acquisitions— (2,557)— — (2,557)— 2,955 — — 2,955 398 
Internal developments— — — — — 10 — — — 10 10 
Transfer of completed development systems — — — — — 65 — (50)(15)— — 
Disposals — — — (2)(2)(891)(3)(29)— (923)(925)
Effect of movements in exchange rates (756)(2,057)(106)(158)(3,077)15 (264)— 466 217 (2,860)
Changes in value on the recognition of inflation effects — — — — — — — — 80 80 80 
Impairment— (770)— — (770)— — — — — (770)
Cost as of December 31, 2022Ps.75,756 Ps.85,704 Ps.9,044 Ps.1,265 Ps.171,769 Ps.10,905 Ps.13,488 Ps.1,977 Ps.5,531 Ps.31,901 Ps.203,670 
(1)Includes customer relationships related to the acquisitions through Envoy Solutions disclosed in Note 4.
Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2023Ps.75,756Ps.85,704Ps.9,044Ps.1,265Ps.171,769Ps.10,905Ps.13,488Ps.1,977Ps.5,531Ps.31,901Ps.203,670
Additions 441,9662611,1743,4013,405
Acquisitions from business combinations (see Note 4) 3,918263,944145188253584,302
Changes in fair value of past acquisitions(12,273)7,683(4,590)5,162(117)5,045455
Business disposals(12)(25,036)(3,009)(56)(28,113)(482)(17,788)(29)(18,299)(46,412)
Transfer of completed development systems (224)2273292(295)(3)
Disposals (2)(2)(4)(197)(161)(235)(593)(597)
Effect of movements in exchange rates (1,568)(3,744)(810)45(6,077)(424)(814)(683)(1,921)(7,998)
Changes in value on the recognition of inflation effects707070
Impairment (4,995)(4,995)(4,995)
Business combinations from disposals1,9501,9501,950
Cost as of December 31, 2023 Ps.73,952Ps.45,522Ps.12,934Ps.1,483Ps.133,891Ps.12,205Ps.236Ps.2,077Ps.5,441Ps.19,959Ps.153,850
(1)Includes customer relationships related to the acquisitions through Envoy Solutions disclosed in Note 4.
Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2024Ps.73,952Ps.45,522Ps.12,934Ps.1,483Ps.133,891Ps.12,205Ps.236Ps.2,077Ps.5,441Ps.19,959Ps.153,850
Additions 461955561,7743881,2103,0753,631
Acquisitions from business combinations (see Note 4) 2,8092,8091,2161,2164,025
Changes in fair value of past acquisitions(3)3
Transfer of completed development systems 670(670)
Disposals (50)(50)(76)(31)(107)(157)
Effect of movements in exchange rates 657(371)289225972,434466145(867)2,1782,775
Changes in value on the recognition of inflation effects256(123)133133
Impairment (1,797)(1,004)(2,801)(2,801)
Cost as of December 31, 2024Ps.74,609Ps.46,624Ps.12,219Ps.1,550Ps.135,002Ps.17,263Ps.702Ps.2,310Ps.6,179Ps.26,454Ps.161,456


Amortization and Impairment LossesRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Amortization as of January 1 2022Ps.Ps.Ps.Ps.Ps.Ps.(6,414)Ps.(1,608)Ps.(838)Ps.(1,172)Ps.(10,032)Ps.(10,032)
Amortization expense (1,312)(915)(104)(365)(2,696)(2,696)
Disposals99215731,1521,152
Effect of movements in exchange rates (193)(786)(248)(1,227)(1,227)
Changes in value on the recognition of inflation effects(94)(1)(95)(95)
Amortization as of December 31 2022 Ps.Ps.Ps.Ps.Ps.Ps.(7,021)Ps.(3,152)Ps.(939)Ps.(1,786)Ps.(12,898)Ps.(12,898)
Amortization as of January 1 2023 Ps.Ps.Ps.Ps.Ps.Ps.(7,021)Ps.(3,152)Ps.(939)Ps.(1,786)Ps.(12,898)Ps.(12,898)
Amortization expense (1,519)(1,113)(116)(547)(3,295)(3,295)
Disposals 161209370370
Business disposals2764,010514,3374,337
Impairment(36)(36)(36)
Effect of movements in exchange rates 57818815187968968
Changes in value on the recognition of inflation effects(78)(78)(78)
Amortization as of December 31 2023 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization as of January 1 2024 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization expense (1,895)(17)(226)(479)(2,617)(2,617)
Disposals 562728585
Effect of movements in exchange rates (745)(745)(648)(413)126(147)(1,082)(1,827)
Changes in value on the recognition of inflation effects (129)(129)(129)
Amortization as of December 31 2024 Ps.(745)Ps.Ps.(36)Ps.Ps.(781)Ps.(10,219)Ps.(470)Ps.(1,140)Ps.(2,510)Ps.(14,339)Ps.(15,120)

Carrying AmountRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
As of December 31 2022Ps.75,756Ps.85,704Ps.9,044Ps.1,265Ps.171,769Ps.3,884Ps.10,336Ps.1,038Ps.3,745Ps.19,003Ps.190,772
As of December 31 2023 Ps.73,952Ps.45,522Ps.12,898Ps.1,483Ps.133,855Ps.4,602Ps.169Ps.1,037Ps.3,555Ps.9,363Ps.143,218
As of December 31 2024 Ps.73,864Ps.46,624Ps.12,183Ps.1,550Ps.134,221Ps.7,044Ps.232Ps.1,170Ps.3,669Ps.12,115Ps.146,336
For the years ended December 31, 2024, December 31, 2023 and 2022, allocation for amortization expense is as follows:
    202420232022
 
Cost of goods sold Ps.49 Ps.1,229 Ps.207 
Administrative expenses 649 1,257 1,771 
Selling expenses 1,919 809 718 
 Ps.2,617 Ps.3,295 Ps.2,696 

The average remaining period for the Company’s intangible assets that are subject to amortization is as follows:
 Years
Technology Costs and Management Systems 
3 - 10
Customer Relationships
6 - 25
Alcohol Licenses 12

Coca-Cola FEMSA Impairment Tests for cash-generating Units Containing Goodwill, Distribution Rights and Other indefinite lived intangible assets
For the purpose of impairment testing, goodwill and distribution rights are allocated and monitored on an individual country basis, which is considered to be the CGU.

The aggregate carrying amounts of goodwill, distribution rights and other indefinite lived intangible assets allocated to each CGU are as follows:
December 31, 2024December 31, 2023
MexicoPs.57,689Ps.56,662
Guatemala1,6951,684
Nicaragua404404
Costa Rica1,4391,418
Panama1,1701,169
Colombia3,6383,635
Brazil28,19930,018
Argentina512245
Uruguay2,4522,381
TotalPs.97,198Ps.97,616

The foregoing forecasts were projected based on actual operating results and the five- year business plan that reflect the outcomes that Coca-Cola FEMSA considers most likely to occur based on the current situation of each of the CGUs including the macroeconomic situation in each CGU, the foregoing forecasts could differ from the results obtained over time.

The value in use of CGUs is determined based on the method of discounted cash flows. The key assumptions used to calculate value in use are: expected volume growth rate, expected annual long-term inflation, and the WACC used to discount the projected flows.

To determine the discount rate, Coca-Cola FEMSA uses the WACC for each of the cash generating units in real terms and as described in following paragraphs.

The estimated discount rates to perform the impairment test for each CGU considers market participants’ assumptions. Market participants were selected considering the size, operations and characteristics of the businesses that are similar to those of Coca-Cola FEMSA.

The discount rates represent the current market assessment of the risks specific to each CGU, taking into consideration the time value of money and individual risks of the underlying assets that have not been incorporated into the projected
cash flows. The discount rate calculation is based on the opportunity cost to a market participant, considering the specific circumstances of Coca-Cola FEMSA and its operating segments and is derived from its WACC. The WACC takes into account both debt and equity. The cost of equity is derived from the expected return on investment by Coca-Cola FEMSA’s investors. The cost of debt is based on the interest-bearing of Coca-Cola FEMSA, which is equivalent to the cost of debt based on the conditions that a creditor would assess in the market. Segment-specific risk is incorporated by applying beta factors which are evaluated annually based on publicly available market data.

Market participant assumptions are important because, not only do they include industry data for growth rates, management also assesses how the CGU’s position, relative to its competitors, might change over the forecasted period.

The key assumptions used for the value-in-use calculations are as follows:
Cash flows were projected based on actual operating results and the five-year business plan.
For discounting cash flows to get the recoverable amount of the units, Coca-Cola FEMSA applies the WACC for each CGU, and the calculation assumes a size premium adjustments.
The key assumptions by CGU for impairment testing as of December 31, 2024 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual Long-Term InflationExpected
Volume Growth Rates
CGU2025‑20292025‑2029
Mexico 9.0%6.3%4.1%5.4%
Brazil 10.9%6.8%3.6%4.1%
Colombia 12.0%7.9%3.1%6.6%
Argentina 16.0%12.0%35.1%4.5%
Guatemala 9.5%7.2%4.0%11.9%
Costa Rica 12.0%8.5%2.8%6.6%
Nicaragua 23.0%13.1%3.5%6.5%
Panama 11.7%9.1%1.8%6.3%
Uruguay 9.5%7.1%5.1%4.2%

The key assumptions by CGU for impairment testing as of December 31, 2023 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual
Long-Term Inflation
Expected
Volume Growth Rates
CGU2024‑20282024‑2028 
Mexico 9.0%6.3%4.3%4.4%
Brazil 10.1%6.8%3.8%3.8%
Colombia 12.2%7.7%4.2%6.8%
Argentina 20.8%16.1%70.8%4.8%
Guatemala 9.3%7.3%4.0%14.9%
Costa Rica 11.4%8.8%2.9%6.6%
Nicaragua 23.3%16.4%2.6%6.5%
Panama11.6%8.6%2.0%7.8%
Uruguay 9.7%7.4%5.7%3.7%


Sensitivity to Changes in Assumptions
On December 31, 2024, Coca-Cola FEMSA performed an additional impairment sensitivity calculation, taking into account an adverse change in post-tax WACC, according to the country risk premium, using for each country the relative standard deviation between equity and sovereign bonds and an additional sensitivity to the volume of 100 basis points and concluded that no impairment would be recorded.
                    
CGUChange in post-tax WACC
Change in Expected Volume Growth CAGR (1)
Effect on Valuation
Mexico 
+0.4
p.p.-1.0%Passes by 5x
Brazil 
+0.5
p.p.-1.0%Passes by 1.9x
Colombia 
+0.7
p.p.-1.0%Passes by 2.5x
Argentina 
+1.7
p.p.-1.0%Passes by 5x
Guatemala 
+0.5
p.p.-1.0%Passes by 7.3x
Costa Rica 
+0.5
p.p.-1.0%Passes by 3.9x
Nicaragua 
+1.7
p.p.-1.0%Passes by 2.1x
Panama 
+0.6
p.p.-1.0%Passes by 3.6x
Uruguay 
+0.1
p.p.-1.0%Passes by 3x
(1)Compound Annual Growth Rate (“CAGR”).

The values assigned to the key assumptions represent management’s assessment of future trends in the industry and are based on both external sources and internal sources (historical data). Coca-Cola FEMSA consistently applied its methodology to determine CGU specific WACC’s to perform its annual impairment testing.

Health Division Impairment Test for cash-generating Units Containing Goodwill and Trademark Rights

For the purpose of impairment testing, goodwill and trademark rights are allocated and monitored on an individual country basis by operating segment. The Company has identified its cash-generating units as follows: Mexico, Chile, Colombia and Ecuador.

As of December 31, 2024 in Health Division there is a carrying amount of goodwill and trademark rights allocated in all countries in which the Company operates as a cash generating unit with a total carrying amount of Ps. 7,074. The aggregate carrying amounts of goodwill and trademark rights allocated to each CGU as of December 31, 2024 are as follows: Chile Ps. 6,383, Colombia Ps. 660 and Ecuador Ps. 31. The aggregate carrying amounts of goodwill and trademark rights allocated to each CGU as of December 31, 2023 are as follows: Mexico Ps. 1,975, Chile Ps. 5,890, Colombia Ps. 634 and Ecuador Ps. 196. Mexico CGU was impaired in 2024 for Ps. 1,975.
The recoverable amounts are based on the value in use. The value in use of CGUs is determined based on the method of discounted cash flows. The key assumptions used in projecting cash flows are: expected sales growth rates, expected annual long-term inflation, and the WACC used to discount the projected cash flows. The cash flow forecasts could differ from the results obtained over time; however, the Company prepares its estimates based on the current situation of each of the CGUs or group of CGUs.
To determine the discount rate, the Company uses the WACC as determined for each of the cash generating units or group of the cash-generating units in real terms and as described in the following paragraphs.
The discount rates represent the current market assessment of the risks specific to each CGU or group of CGUs, taking into consideration the time value of money and individual risks of the underlying assets that have not been incorporated in the cash flow estimates. The discount rate calculation is based on the opportunity cost to a market participant, considering the specific circumstances of the Company and its operating segments and is derived from its WACC.
Market participant assumptions are important because, not only do they include industry data for growth rates, management also assesses how the CGU’s position, relative to its competitors, might change over the forecasted period.
The key assumptions used for the value-in-use calculations are as follows:
Cash flows were projected based on actual operating results and the five-year business plan.
For discounting cash flows to get the recoverable amount of the units, the Company applies the WACC for each CGU, and the calculation assumes a size premium adjustments.
The key assumptions by the significant CGU (Chile) in the Health Division (Mexico, Colombia and Ecuador are insignificant) for impairment test as of December 31, 2024 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2025‑2029
Expected Sales Growth Rate
Chile 6.8%5.9%3.1%1.9%

The key assumptions by the significant CGU in the Health Division for impairment test as of December 31, 2023 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2024‑2028
Expected Sales Growth Rates 2024‑2028
Chile7.3 %6.4 %2.6 %0.2 %

The values assigned to the key assumptions represent management’s assessment of future trends in the industry and are based on both external sources and internal sources (historical data). The Company consistently applied its methodology to determine CGU specific WACCs to perform its annual impairment testing.
Sensitivity to Changes in Assumptions
On December 31, 2024, the Company performed an additional impairment sensitivity calculation, taking into account an adverse change in post-tax WACC, according to the country risk premium, using for each country the relative standard deviation between equity and sovereign bonds and a sensitivity analysis of sales that would be affected considering a contraction in economic conditions as a result of lower purchasing power of customers, which based on management estimation considered to be reasonably possible an effect of 50 basis points in the sale’s CAGR, concluding that no impairment would be recognized.
The sensitivity test by the significant CGU in the Health Division as of December 31, 2024 was as follows:
CGUChange in WACCChange in Expected Sales Growth Rates CAGREffect on Valuation
Chile 0.3p.p.(0.5)%Passes by 6.24x


Valora impairment testing for cash-generating units containing goodwill.
The Company has identified its cash-generating units as a retail food distribution platform located in Europe for impairment testing purposes for goodwill and trademark rights.

As of December 31, 2024 in Valora there is a significant carrying amount of goodwill and trademarks allocated in the cash generating unit with a total carrying amount of Ps. 21,560.
The recoverable amounts are based on the value in use. The value in use of the CGU is determined based on the method of discounted cash flows. The key assumptions used in projecting cash flows are: expected sales growth rates, expected annual long-term inflation, and the WACC used to discount the projected cash flows. The cash flow forecasts could differ from the results obtained over time; however, the Company prepares its estimates based on the current situation of the CGU.

To determine the discount rate, the Company uses the WACC as determined for each of the cash generating units or group of the cash generating units in real terms and as described in following paragraphs.

The discount rates represent the current market assessment of the risks specific to the CGU, taking into consideration the time value of money and individual risks of the underlying assets that have not been incorporated in the cash flow estimates. The discount rate calculation is based on the opportunity cost to a market participant, considering the specific circumstances of the Company and its operating segments and is derived from its WACC.
Market participant assumptions are important because, not only do they include industry data for growth rates, management also assesses how the CGU’s position, relative to its competitors, might change over the forecasted period.

The key assumptions used for the value-in-use calculations are as follows:
Cash flows were projected based on actual operating results and the five-year business plan.
For discounting cash flows to get the recoverable amount of the units, the Company applies the WACC for the CGU, and the calculation assumes a size premium adjustment.

The key assumptions by CGU for impairment test as of December 31, 2024 were as follows:

CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2025‑2029
Expected Sales Growth Rates
Valora 5.7%5.3%1.0%4.5%
The key assumptions by CGU for impairment test as of December 31, 2023 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual Long-Term Inflation 2024‑2028Expected Sales Growth Rates 2024‑2028
Valora 5.8%5.5%1.4%0.2%

The values assigned to the key assumptions represent management’s assessment of future trends in the industry and are based on both external sources and internal sources (historical data). The Company consistently applied its methodology to determine CGU specific WACC’s to perform its annual impairment testing.

Sensitivity to Changes in Assumptions

On December 31, 2024, the Company performed an additional impairment sensitivity calculation, taking into account an effect of 50 basis points in the sale’s compound annual growth rate (“CAGR”), concluding that no impairment would be recognized.

CGUChange in Expected Sales Growth CAGREffect on Valuation
Valora (0.5)%Passes by 1.45x